查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423553

到 2030 年脑血管栓塞的市场预测：按产品、程序、最终用户和地区进行的全球分析

Neurovascular Embolization Market Forecasts to 2030 - Global Analysis By Product, Procedure (Arteriovenous Malformation Embolization, Aneurysm Coiling and Embolization and Other Procedures), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球脑血管栓塞市场规模为 15.2 亿美元，预计预测期内复合年增长率为 8.4%，到 2030 年将达到 26.7 亿美元。

脑血管栓塞是一种用于治疗影响大脑和神经系统血管的各种疾病的医疗程序。这涉及故意将栓塞剂（例如颗粒、线圈或液体物质）引入血管中，以阻止或减少流向用于治疗异常血管结构的目标区域的血流。此外，透过阻断或减少受影响血管的血流，脑血管栓塞可以帮助缓解症状，防止进一步损伤，并促进整体血管稳定性。

根据脑动脉瘤基金会的数据，美国约有 670 万人患有未破裂的脑动脉瘤，每年每 10 万人中有 8 至 10 例破裂。

扩大医疗基础设施

扩大医疗保健基础设施可以促进医疗保健提供者、行业相关人员和监管机构之间的合作，并促进研究和开发倡议。这种扩展不仅可以解决神经血管疾病日益增加的负担，而且可以及时诊断和介入。此外，协作环境支持栓塞材料、输送系统和技术的持续改进，为整个脑血管栓塞领域的进步做出贡献。

认识和教育有限

由于认知度低，脑血管栓塞未充分利用，患者被迫选择替代治疗。缺乏有关该程序的公众教育宣传活动和资讯普及导致诊断和治疗的延误。此外，脑血管栓塞很复杂，需要专门的技术来执行，这为普及造成了障碍并阻碍了市场扩张。

技术进步

栓塞剂、传输系统和成像技术的技术进步和创新显着提高了脑血管栓塞的准确性、安全性和有效性。先进的输送系统，包括微导管和导航工具，使神经干预医生能够到达复杂的血管结构。此外，人工智慧 (AI) 和机器学习的整合进一步完善了手术规划和执行，优化结果并缩短手术时间。

经济萧条

景气衰退影响接受脑血管栓塞的患者的经济能力，常常面临限制和成本削减措施。这可能会减少医疗程序的资金，个人在确保足够的健康保险覆盖方面可能面临挑战或资源有限。此外，景气衰退可能会扰乱整个医疗保健生态系统，包括医生的做法和转诊模式。医生可能会遇到患者数量或营业额下降的情况，这阻碍了这个市场。

COVID-19 的影响

COVID-19大流行对脑血管栓塞市场产生了一些负面影响。疫情导致全球医疗保健服务中断，涉及栓塞等某些神经血管干预措施的手术被推迟或取消，影响了整体手术量。后勤挑战也影响了医疗设备的可得性，包括用于脑栓塞的设备。此外，不断变化的医疗保健优先事项和医疗保健系统的财务压力也阻碍了这个市场规模。

预计在预测期内，栓塞线圈细分市场将成为最大的细分市场

栓塞弹簧圈领域预计将占据最大的市场份额，因为它专注于脑血管异常的治疗。该技术涉及透过导管将铂或其他生物相容性线圈直接放入血管中。这些线圈诱导血块形成，促进自然癒合过程，并防止破裂的风险。此外，其在治疗脑血管疾病（包括动脉瘤和动静脉畸形）方面的多功能性，加上正在进行的研究和开发工作，正在推动该领域的扩张。

动脉瘤弹簧圈栓塞/栓塞预计在预测期内具有最高的复合年增长率

动脉瘤弹簧圈栓塞和栓塞领域预计在预测期内复合年增长率最高。动脉瘤弹簧圈栓塞是脑血管异常的重要治疗方法，将导管引导穿过血管到达动脉瘤部位。然后将铂线圈或其他栓塞装置放入动脉瘤中，以促进血块形成并防止破裂。此外，动脉瘤弹簧圈栓塞和栓塞侵入性较小，恢復时间较短，併发症风险较低，从而提高了医疗保健专业人员和患者的认识，这将继续推动该市场的成长。

比最大的地区

由于需求的增加和医疗基础设施的进步，亚太地区在预测期内占据了最大的市场占有率。医疗保健意识的提高、诊断能力的提高以及医疗服务获取范围的扩大正在推动对脑血管栓塞的需求。此外，医疗机构和行业相关人员之间的合作促进了创新栓塞材料和设备的开发和引进，推动了该地区的成长。

复合年增长率最高的地区：

由于对包括栓塞的先进介入神经放射学治疗的认识不断提高，预计欧洲在预测期内将表现出最高的复合年增长率。 Medtronic plc、Penumbra, Inc、MicroVention 和 Acandis GmbH 等主要企业继续推动医疗保健系统的技术进步，并为改善患者治疗结果做出贡献。此外，动脉瘤和动静脉疾病等脑血管疾病的增加正在推动该地区的扩张。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球脑血管栓塞市场：按产品

  • 分流器
  • 动脉瘤夹
  • 栓塞圈
  • 液态栓塞剂/系统
  • 其他产品

第六章全球脑血管栓塞市场：依程序

  • 动静脉畸形（AVM）栓塞
  • 动脉瘤弹簧圈栓塞
  • 其他治疗

第七章全球脑血管栓塞市场：依最终使用者分类

  • 专科诊所
  • 医院
  • 其他最终用户

第八章全球脑栓塞市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • Cerenovus
  • Penumbra Inc
  • Medtronic
  • Phenox GmbH
  • Stryker
  • Balt SAS
  • Shape Memory Medical Inc
  • Integra LifeSciences
  • B. Braun Melsungen AG
  • MicroVention Inc
  • Peter Lazic GmbH
  • Spartan Micro
Product Code: SMRC24787

According to Stratistics MRC, the Global Neurovascular Embolization Market is accounted for $1.52 billion in 2023 and is expected to reach $2.67 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Neurovascular embolization is a medical procedure used to treat various conditions affecting the blood vessels of the brain and nervous system. It involves the intentional introduction of embolic agents, such as particles, coils, or liquid substances, into the blood vessels to block or reduce blood flow to targeted areas employed to treat abnormal vascular structures. Furthermore, by occluding or reducing blood flow to the affected vessels, neurovascular embolization helps to alleviate symptoms, prevent further damage, and promote overall vascular stability.

According to the Brain Aneurysms Foundation, in the U.S., roughly 6.7 million people have unruptured brain aneurysms, leading to an annual rupture rate of 8-10 cases per 100,000.

Market Dynamics:

Driver:

Expansion of Healthcare Infrastructure

The expansion of healthcare infrastructure facilitates collaborative efforts between healthcare institutions, industry stakeholders, and regulatory bodies, fostering research and development initiatives. This expansion not only addresses the growing burden of neurovascular disorders but also enables timely diagnosis and intervention. Moreover, a collaborative environment supports the continuous improvement of embolic materials, delivery systems, and procedural techniques, contributing to the overall advancement of the neurovascular embolization field.

Restraint:

Limited awareness and education

The limited awareness can lead to underutilization of neurovascular embolization, with patients being directed towards alternative treatments. Lack of public education campaigns and information dissemination about the procedure can result in delayed diagnosis and treatment. Furthermore, the complexity of neurovascular embolization and the specialized skills required to perform the procedure can be a barrier to its widespread adoption, which is impeding this market expansion.

Opportunity:

Technological advancements

The advancements in technology and innovations in embolic materials, delivery systems, and imaging technologies have significantly improved the precision, safety, and efficacy of neurovascular embolization procedures. Advanced delivery systems, including microcatheters and navigation tools, enable neurointerventionalists to reach intricate vascular structures. Furthermore, the integration of artificial intelligence (AI) and machine learning further refines procedural planning and execution, optimizing outcomes and reducing procedural times, which drive this market growth.

Threat:

Economic downturns

Economic downturns impact patients' ability to afford neurovascular embolization procedures and often face constraints and cost-cutting measures. This can lead to a reduction in funding for medical procedures, and individuals may face challenges in securing adequate health insurance coverage or may have limited resources. Additionally, economic downturns can disrupt the overall healthcare ecosystem, including physician practices and referral patterns. Physicians may experience reduced patient volumes or changes, which are hampering this market.

Covid-19 Impact

The COVID-19 pandemic has had several negative impacts on the neurovascular embolization market. The pandemic led to disruptions in healthcare services globally, procedures including certain neurovascular interventions like embolization, which were deferred or cancelled, impacting the overall procedural volume. Logistic challenges also impacted the availability of medical devices, including those used in neurovascular embolization. In addition, the shift in healthcare priorities and the financial strain on healthcare systems also hindered this market size.

The embolic coils segment is expected to be the largest during the forecast period

The embolic coil segment is estimated to hold the largest share due to its focus on the treatment of vascular abnormalities in the brain. This technique involves the deployment of platinum or other biocompatible coils through a catheter directly into the blood vessel. These coils induce clot formation, promoting the natural healing process and preventing the risk of rupture. In addition, it is versatile in treating cerebrovascular conditions, including aneurysms and arteriovenous malformations, coupled with ongoing research and development efforts that are boosting this segment's expansion.

The aneurysm coiling and embolization segment is expected to have the highest CAGR during the forecast period

The aneurysm coiling and embolization segment is anticipated to have highest CAGR during the forecast period. It is a crucial intervention for treating vascular abnormalities in the brain, wherein a catheter is navigated through blood vessels to the site of the aneurysm. Platinum coils or other embolic devices are then deployed into the aneurysm, promoting blood clot formation and preventing rupture. Furthermore, aneurysm coiling and embolization procedures offer reduced invasiveness, shorter recovery times, and a lower risk of complications, and rising awareness among both healthcare providers and patients contributes to the sustained growth of this market.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period, owing to increased demand and advancements in healthcare infrastructure. Increasing healthcare awareness, improved diagnostic capabilities, and expanding access to healthcare services have heightened the demand for neurovascular embolization procedures. Furthermore, collaborative efforts between healthcare institutions and industry players have resulted in the development and introduction of innovative embolic materials and devices, which are driving this region's growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to a growing awareness of advanced neurointerventional procedures, including embolization. Key players such as Medtronic plc, Penumbra, Inc., MicroVention, and Acandis GmbH continue to evolve technological advancements in healthcare systems, contributing to improved patient outcomes. Furthermore, increasing incidences of cerebrovascular diseases, such as aneurysms and arteriovenous, are propelling this region's expansion.

Key players in the market

Some of the key players in the Neurovascular Embolization Market include Cerenovus, Penumbra Inc, Medtronic, Phenox GmbH, Stryker, Balt SAS, Shape Memory Medical Inc, Integra LifeSciences, B. Braun Melsungen AG, MicroVention Inc, Peter Lazic GmbH and Spartan Micro.

Key Developments:

In August 2023, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review data presented in support of the Medtronic Symplicity Spyral™ Renal Denervation (RDN) System.

In February 2022, CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices Companies,* announced the launch of EMBOGUARD™, a next generation balloon guide catheter to be used in endovascular procedures, including those for patients with acute ischemic stroke.

In June 2021, Johnson & Johnson Medical Devices Companies* announced the first patient was enrolled in the CERENOVUS-sponsored MEMBRANE study evaluating TruFill® n-BCA Liquid Embolic System in the embolization of middle meningeal artery (MMA) for treatment of chronic subdural hematoma (cSDH) as adjunct to surgical evacuation or as a stand-alone treatment.

In January 2020, MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms.

Products Covered:

  • Flow Diversion Devices
  • Aneurysm Clips
  • Embolic Coils
  • Liquid Embolic Agents/Systems
  • Other Products

Procedures Covered:

  • Arteriovenous Malformation (AVM) Embolization
  • Aneurysm Coiling and Embolization
  • Other Procedures

End Users Covered:

  • Specialty Clinics
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurovascular Embolization Market, By Product

  • 5.1 Introduction
  • 5.2 Flow Diversion Devices
  • 5.3 Aneurysm Clips
  • 5.4 Embolic Coils
  • 5.5 Liquid Embolic Agents/Systems
  • 5.6 Other Products

6 Global Neurovascular Embolization Market, By Procedure

  • 6.1 Introduction
  • 6.2 Arteriovenous Malformation (AVM) Embolization
  • 6.3 Aneurysm Coiling and Embolization
  • 6.4 Other Procedures

7 Global Neurovascular Embolization Market, By End User

  • 7.1 Introduction
  • 7.2 Specialty Clinics
  • 7.3 Hospitals
  • 7.4 Other End Users

8 Global Neurovascular Embolization Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Cerenovus
  • 10.2 Penumbra Inc
  • 10.3 Medtronic
  • 10.4 Phenox GmbH
  • 10.5 Stryker
  • 10.6 Balt SAS
  • 10.7 Shape Memory Medical Inc
  • 10.8 Integra LifeSciences
  • 10.9 B. Braun Melsungen AG
  • 10.10 MicroVention Inc
  • 10.11 Peter Lazic GmbH
  • 10.12 Spartan Micro

List of Tables

  • Table 1 Global Neurovascular Embolization Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 4 Global Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 5 Global Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 6 Global Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 7 Global Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 8 Global Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 9 Global Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 10 Global Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 11 Global Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 12 Global Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 13 Global Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 14 Global Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 15 Global Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 16 North America Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
  • Table 17 North America Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 18 North America Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 19 North America Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 20 North America Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 21 North America Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 22 North America Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 23 North America Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 24 North America Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 25 North America Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 26 North America Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 27 North America Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 28 North America Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 29 North America Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 30 North America Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 31 Europe Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
  • Table 32 Europe Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 33 Europe Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 34 Europe Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 35 Europe Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 36 Europe Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 37 Europe Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 38 Europe Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 39 Europe Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 40 Europe Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 41 Europe Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 42 Europe Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 43 Europe Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 44 Europe Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 45 Europe Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 46 Asia Pacific Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
  • Table 47 Asia Pacific Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 48 Asia Pacific Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 49 Asia Pacific Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 50 Asia Pacific Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 51 Asia Pacific Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 52 Asia Pacific Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 53 Asia Pacific Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 54 Asia Pacific Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 55 Asia Pacific Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 56 Asia Pacific Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 57 Asia Pacific Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 58 Asia Pacific Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 59 Asia Pacific Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 60 Asia Pacific Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 South America Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 South America Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 63 South America Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 64 South America Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 65 South America Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 66 South America Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 67 South America Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 68 South America Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 69 South America Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 70 South America Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 71 South America Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 72 South America Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 73 South America Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 74 South America Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 75 South America Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 76 Middle East & Africa Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
  • Table 77 Middle East & Africa Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
  • Table 78 Middle East & Africa Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
  • Table 79 Middle East & Africa Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
  • Table 80 Middle East & Africa Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
  • Table 81 Middle East & Africa Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
  • Table 82 Middle East & Africa Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 83 Middle East & Africa Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 84 Middle East & Africa Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
  • Table 85 Middle East & Africa Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
  • Table 86 Middle East & Africa Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 87 Middle East & Africa Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
  • Table 88 Middle East & Africa Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 89 Middle East & Africa Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 90 Middle East & Africa Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)